Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Primary Aldosteronism
Gian Paolo Rossi
Journal of the American College of Cardiology (2019) Vol. 74, Iss. 22, pp. 2799-2811
Closed Access | Times Cited: 125

Showing 1-25 of 125 citing articles:

The Unrecognized Prevalence of Primary Aldosteronism
Jenifer M. Brown, Mohammed Siddiqui, David A. Calhoun, et al.
Annals of Internal Medicine (2020) Vol. 173, Iss. 1, pp. 10-20
Open Access | Times Cited: 430
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
John W. McEvoy, Cian P. McCarthy, Rosa María Bruno, et al.
European Heart Journal (2024)
Closed Access | Times Cited: 322
Oxidative Stress: A Unifying Paradigm in Hypertension
Rhian M. Touyz, Francisco J. Rios, Rhéure Alves-Lopes, et al.
Canadian Journal of Cardiology (2020) Vol. 36, Iss. 5, pp. 659-670
Open Access | Times Cited: 213
The 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism
Gian Paolo Rossi, Valeria Bisogni, Alessandra Bacca, et al.
International Journal of Cardiology Hypertension (2020) Vol. 5, pp. 100029-100029
Open Access | Times Cited: 106
Evolution of the Primary Aldosteronism Syndrome: Updating the Approach
Anand Vaidya, Robert M. Carey
The Journal of Clinical Endocrinology & Metabolism (2020) Vol. 105, Iss. 12, pp. 3771-3783
Open Access | Times Cited: 106
Practice Recommendations for Diagnosis and Treatment of the Most Common Forms of Secondary Hypertension
Gian Paolo Rossi, Valeria Bisogni, Giacomo Rossitto, et al.
High Blood Pressure & Cardiovascular Prevention (2020) Vol. 27, Iss. 6, pp. 547-560
Open Access | Times Cited: 106
Pathogenesis and treatment of primary aldosteronism
Maria‐Christina Zennaro, Sheerazed Boulkroun, Fábio L. Fernandes‐Rosa
Nature Reviews Endocrinology (2020) Vol. 16, Iss. 10, pp. 578-589
Open Access | Times Cited: 95
Primary Aldosteronism: State-of-the-Art Review
Anand Vaidya, Gregory L. Hundemer, Kazutaka Nanba, et al.
American Journal of Hypertension (2022) Vol. 35, Iss. 12, pp. 967-988
Open Access | Times Cited: 65
Molecular and Epigenetic Control of Aldosterone Synthase, CYP11B2 and 11-Hydroxylase, CYP11B1
Yoshimichi Takeda, Masashi Demura, Mitsuhiro Kometani, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5782-5782
Open Access | Times Cited: 24
Approach to Endocrine Hypertension: A Case-Based Discussion
Sanja Borozan, A B Kamrul-Hasan, Sahana Shetty, et al.
Current Hypertension Reports (2025) Vol. 27, Iss. 1
Open Access | Times Cited: 1
Aldosterone and cardiovascular diseases
Wasita Warachit Parksook, Gordon H. Williams
Cardiovascular Research (2022) Vol. 119, Iss. 1, pp. 28-44
Open Access | Times Cited: 29
Liquorice Toxicity: A Comprehensive Narrative Review
Giovanna Ceccuzzi, Alessandro Rapino, Benedetta Perna, et al.
Nutrients (2023) Vol. 15, Iss. 18, pp. 3866-3866
Open Access | Times Cited: 18
Clinical Management of Primary Aldosteronism: An Update
Gian Paolo Rossi, Federico Bernardo Rossi, Chiara Guarnieri, et al.
Hypertension (2024) Vol. 81, Iss. 9, pp. 1845-1856
Closed Access | Times Cited: 8
Cerebro-Cardiovascular Risk, Target Organ Damage, and Treatment Outcomes in Primary Aldosteronism
Xiao Lin, Muhammad Hasnain Ehsan Ullah, Wu Xiong, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 8
Open Access | Times Cited: 26
Primary Aldosteronism and Resistant Hypertension: A Pathophysiological Insight
Fabio Bioletto, Martina Bollati, Chiara Lopez, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4803-4803
Open Access | Times Cited: 26
Clinical Value of68Ga-Pentixafor PET/CT in Subtype Diagnosis of Primary Aldosteronism Patients with Adrenal Micronodules
Jie Ding, Xiang Li, Shengyan Liu, et al.
Journal of Nuclear Medicine (2023) Vol. 65, Iss. 1, pp. 117-124
Open Access | Times Cited: 16
Aldosterone and aldosterone synthase inhibitors in cardiorenal disease
Subodh Verma, Avinash Pandey, Arjun Pandey, et al.
AJP Heart and Circulatory Physiology (2023) Vol. 326, Iss. 3, pp. H670-H688
Closed Access | Times Cited: 15
What We Know about and What Is New in Primary Aldosteronism
Natalia Ekman, Ashley Grossman, Dorota Dworakowska
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 900-900
Open Access | Times Cited: 5
Aldosterone synthase inhibitors for cardiovascular diseases: A comprehensive review of preclinical, clinical and in silico data
Livia Lenzini, Giuseppe Zanotti, Marcella Bonchio, et al.
Pharmacological Research (2020) Vol. 163, pp. 105332-105332
Closed Access | Times Cited: 33
DNA Methylation of the Angiotensinogen Gene, AGT, and the Aldosterone Synthase Gene, CYP11B2 in Cardiovascular Diseases
Yoshimichi Takeda, Masashi Demura, Takashi Yoneda, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4587-4587
Open Access | Times Cited: 28
Diagnosis and management of primary hyperaldosteronism in patients with hypertension: a practical approach endorsed by the British and Irish Hypertension Society
Luca Faconti, Spoorthy Kulkarni, Christian Delles, et al.
Journal of Human Hypertension (2023) Vol. 38, Iss. 1, pp. 8-18
Open Access | Times Cited: 11
‘Essential’ arterial hypertension: time for a paradigm change
Gian Paolo Rossi, Domenico Bagordo, Federico Bernardo Rossi, et al.
Journal of Hypertension (2024) Vol. 42, Iss. 8, pp. 1298-1304
Open Access | Times Cited: 4
Adrenal artery ablation for primary aldosteronism without apparent aldosteronoma: An efficacy and safety, proof‐of‐principle trial
Hexuan Zhang, Qiang Li, Xiaoli Liu, et al.
Journal of Clinical Hypertension (2020) Vol. 22, Iss. 9, pp. 1618-1626
Open Access | Times Cited: 29
Device Therapy of Hypertension
Felix Mahfoud, Markus P. Schlaich, Melvin D. Lobo
Circulation Research (2021) Vol. 128, Iss. 7, pp. 1080-1099
Open Access | Times Cited: 25
Autonomous cortisol secretion is associated with worse arterial stiffness and vascular fibrosis in primary aldosteronism: a cross-sectional study with follow-up data
Cheng‐Hsuan Tsai, Che‐Wei Liao, Xue-Ming Wu, et al.
European Journal of Endocrinology (2022) Vol. 187, Iss. 1, pp. 197-208
Closed Access | Times Cited: 18
Page 1 - Next Page

Scroll to top